Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
New Approaches to Neuroblastoma Therapy Consortium
Immatics Biotechnologies GmbH
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Cancer Research UK
SWOG Cancer Research Network
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center